Joshua D Palmer, MD
Academic Title: Associate Professor in the College of Medicine
Research Program: Translational Therapeutics
About Me
More info forI am a radiation oncologist specializing in the treatment of central nervous system (CNS) malignancies, such as primary and secondary brain tumors as well as cancers of the spine. I am also the pediatric malignancy disease site leader and a committed physician-scientist, devoting a significant portion of my professional time to prospective clinical trials and strategies to improve the efficacy of radiation. I have published over 100 manuscripts, book chapters and abstracts, including publications in such leading medical journals as Cancer Cell, Lancet Oncology, JAMA Oncology, Radiotherapy and Oncology, and Journal of Neuro-Oncology and Neurology. My research focuses on translational oncology, biomarker discovery and the interaction of diet on cancer therapy. I serve as a national co-PI on three brain metastasis trials in the NRG Oncology and ALLIANCE for Clinical Trials groups, as well as on several studies through the Children’s Oncology Group. I am also a member of the International Guideline Harmonization Group for neurocognitive problems and colorectal cancer, and a committee member on the National Comprehensive Cancer Network’s pediatric CNS tumors national guidelines. Cancer can be a very scary diagnosis — there’s a lot of anxiety involved — but it is also very complex. It’s important for doctors to use their experience and expertise to distill the information as best as possible so that patients can understand what their treatment options are and best formulate their goals of care. I focus my time and effort to ensure that patients and their families understand the diagnosis and treatment plan. My role is to be an advocate and information source so that patients can make the best decisions for themselves. I take a multidisciplinary approach to cancer care by working with several different teams, including the skull base tumor group, the spine tumor group, the CNS tumor group, and the pediatric sarcoma and CNS tumor group. It is this close collaboration among the various teams that makes The James such a great place to work. We have the absolute best nurses, physicists, dosimetrists and therapists in the world, and that allows me to be more effective in my role. In addition to my clinical and research work, I serve as an assistant professor in the Department of Radiation Oncology at The Ohio State University. I am also a member of several professional organizations, including the American Society of Therapeutic Radiation Oncology, the American Society of Clinical Oncology, the American College of Radiology and the American College of Radiation Oncology. I have research funding from Varian Medical Systems, Kroger and the Ohio State University Comprehensive Cancer Center, and I serve as a consultant for Huron Consulting Group and Novocure.
Clinical Expertise
More info for- Skull Base Tumors
- Brain Cancers
- Radiation Oncology
- Spinal Cord Tumors
Where I See Patients
More info forThe Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
460 W. 10th Ave. Columbus, Ohio 43210 800-293-5066 Location InformationEducation & Training
More info forInternship - Internal Medicine
- New York University School of Medicine
550 1St Ave, New York, NY
Residency - Radiation Oncology
- Thomas Jefferson University Hospital
111 S 11Th St, Philadelphia, PA
Medical School
- University of Miami School of Medicine
1600 Nw 10Th Ave, Miami, FL
- New York University School of Medicine
Academic Office & Contact Information
More info forAcademic Office:
James Cancer Hospital C0227
460 W 10th Ave
Columbus, Ohio 43210-1240Email:
Joshua.Palmer@osumc.eduPublications
More info forOctober 18, 2024Comparative analysis of stereotactic radiosurgery outcomes for supratentorial hemangioblastomas in von hippel-lindau disease and sporadic cases: A multi-center international study.
Tos SM, Hajikarimloo B, Mantziaris G, Shaaban A, Pham D, Dayawansa S, Wei Z, McKendrick LM, Niranjan A, Lunsford LD, Peker S, Samanci Y, Liscak R, May J, Mathieu D, Picozzi P, Franzini A, Warnick RE, Schoenhals JE, Palmer JD, Xu Z, Sheehan JP
J Clin Neurosci
October 4, 2024Impact of instrumentation material on local recurrence: a case-matched series using carbon fiber-PEEK vs. titanium.
Ward J, Damante M, Wilson S, Coelho V, Franceschelli D, Elguindy AN, Thomas EM, Zhu S, Blakaj D, Beyer S, Raval R, Singh R, Xu DS, Elder JB, Palmer JD, Chakravarthy VB
J Neurooncol
October 1, 2024Comparison of Repeat Versus Initial Stereotactic Radiosurgery for Intracranial Arteriovenous Malformations: A Retrospective Multicenter Matched Cohort Study.
Orrego Gonzalez E, Mantziaris G, Shaaban A, Starke RM, Ding D, Lee JYK, Mathieu D, Kondziolka D, Feliciano C, Grills IS, Barnett GH, Lunsford LD, Lišcák R, Lee CC, Martinez Álvarez R, Peker S, Samanci Y, Cockroft KM, Tripathi M, Palmer JD, Zada G, Cifarelli CP, Nabeel AM, Pikis S, Sheehan JP
Neurosurgery
October 1, 2024Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial.
Oh J, Skinner L, Gutkin PM, Jiang A, Donaldson SS, Loo BW, Wang YP, Ewongwo A, Bredfeldt JS, Breneman JC, Constine LS, Faught AM, Haas-Kogan D, Holmes JA, Krasin M, Larkin C, Marcus KJ, Maxim PG, McClelland S, Murphy B, Palmer JD, Perkins SM, Shen CJ, Terezakis S, Bush K, Hiniker SM
Adv Radiat Oncol
September 28, 2024A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence.
Nguyen MP, Morshed RA, Youngblood MW, Perlow HK, Lucas CG, Patel AJ, Palmer JD, Horbinski CM, Magill ST, Chen WC, Raleigh DR
Neuro Oncol
September 2, 2024Radiosurgery Society Case-Based Guide to Stereotactic Body Radiation Therapy for Challenging Cases of Spinal Metastases.
Aziz K, Koffler D, Vassantachart A, Rattani A, Ankrah NK, Gogineni E, Andraos TY, Sahgal A, Vellayappan B, Dunne EM, Siva S, Moraes FY, Guckenberger M, Lubelski D, Chao S, Combs S, Chang E, Amin AG, Foote M, Gibbs I, Kim M, Palmer J, Lo S, Redmond KJ
Pract Radiat Oncol
September 1, 2024Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imaging.
Kwak S, Akbari H, Garcia JA, Mohan S, Dicker Y, Sako C, Matsumoto Y, Nasrallah MP, Shalaby M, O'Rourke DM, Shinohara RT, Liu F, Badve C, Barnholtz-Sloan JS, Sloan AE, Lee M, Jain R, Cepeda S, Chakravarti A, Palmer JD, Dicker AP, Shukla G, Flanders AE, Shi W, Woodworth GF, Davatzikos C
J Med Imaging (Bellingham)
August 30, 2024PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer.
Yadav D, Dutruel SP, O'Dwyer E, Ricaurte-Fajardo A, Upadhyay R, Palmer JD, Pannullo SC, Tagawa ST, Knisely JPS, Brandmaier A, Osborne JR, Ivanidze J
Eur J Radiol
August 5, 2024Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma.
Morshed RA, Nguyen MP, Youngblood MW, Perlow HK, Lucas CG, Patel AJ, Palmer JD, Chandler JP, Theodosopoulos PV, Magill ST, Chen WC, Raleigh DR
Neurosurgery
August 1, 2024Stereotactic Ablative Radiation Therapy (SABR) for Adolescent and Young Adult Malignancies.
Singh R, Bishop S, Jenkins J, Davis J, Upadhyay R, McLaughlin C, Sharma S, Baliga S, Palmer JD
Cureus
July 24, 2024Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).
Pike LRG, Miao E, Boe LA, Patil T, Imber BS, Myall NJ, Pollom EL, Hui C, Qu V, Langston J, Chiang V, Grant M, Goldberg SB, Palmer JD, Prasad RN, Wang TJC, Lee A, Shu CA, Chen LN, Thomas NJ, Braunstein SE, Kavanagh BD, Camidge DR, Rusthoven CG
J Clin Oncol
July 18, 2024Letter: Evaluating the Role of Preoperative Stereotactic Radiosurgery Followed by Separation Surgery for the Management of Spinal Metastases.
Martins Coelho Junior VP, Palmer J, Chakravarthy V
Neurosurgery
July 5, 2024A Case-based Guide for World Health Organization (WHO) Grade 2 Meningioma Radiosurgery and Radiation Therapy from The Radiosurgery Society.
Vassantachart AK, Ehret F, Chen E, Kumar R, Gogineni E, Andraos TY, Sahgal A, Redmond KJ, Lo SS, Chang EL, Sheehan J, Chao ST, Kim GG, Kresl JJ, Schulder M, Palmer JD, Gibbs IC, Santacroce A, Shih HA
Pract Radiat Oncol
July 1, 2024Safety and Feasibility of Stereotactic Radiosurgery for Patients with 15 or more Brain Metastases.
Upadhyay R, Palmer JD, Klamer BG, Perlow HK, Schoenhals JE, Ghose J, Rajappa P, Blakaj DM, Beyer S, Grecula JC, Sim AJ, Lu L, Zoller W, Elder JB, Chakravarti A, Thomas E, Raval RR
Adv Radiat Oncol
June 29, 2024Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.
Mrugala MM, Shi W, Iwomoto F, Lukas RV, Palmer JD, Suh JH, Glas M
J Neurooncol
June 28, 2024Pleomorphic Xanthoastrocytoma: Multi-Institutional Evaluation of Stereotactic Radiosurgery.
Düzkalir AH, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, Abdelkarim K, El-Shehaby AMN, Emad RM, Martínez Moreno N, Martínez Álvarez R, Mathieu D, Niranjan A, Lunsford LD, Wei Z, Shanahan RM, Liscak R, May J, Dono A, Blanco AI, Esquenazi Y, Dayawansa S, Sheehan J, Tripathi M, Shepard MJ, Wegner RE, Upadhyay R, Palmer JD, Peker S
Neurosurgery
June 20, 2024Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
Albert NL, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer JD, Guedj E, Furtner J, Fraioli F, Huang RY, Johnson DR, Deroose CM, Herrmann K, Vogelbaum M, Chang S, Tonn JC, Weller M, Wen PY, van den Bent MJ, Verger A, Ivanidze J, Galldiks N
Eur J Nucl Med Mol Imaging
May 30, 2024Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients.
Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH, Singh R, Raval RR, Palmer JD, Baliga S
Cancers (Basel)
May 6, 2024Long-term Outcomes of Surgery and Radiation Treatment for Adult Patients with Craniopharyngioma.
Poiset SJ, Song A, In Yoon H, Huang J, Jain S, Palmer JD, Matsui JK, Cappelli L, Mazza JM, Ali AS, Evans JJ, Farrell CJ, Kearns KN, Sheehan JP, Shi W
World Neurosurg
April 29, 2024Sex-specific Differences in IDH1-Wildtype Glioblastoma patients in the ReSPOND Consortium.
Gongala S, Garcia JA, Korakavi N, Patil N, Akbari H, Sloan A, Barnholtz-Sloan JS, Sun J, Griffith B, Poisson LM, Booth TC, Jain R, Mohan S, Nasralla MP, Bakas S, Tippareddy C, Puig J, Palmer JD, Shi W, Colen RR, Sotiras A, Ahn SS, Park YW, Davatzikos C, Badve C
AJNR Am J Neuroradiol
April 17, 2024Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM).
Gallitto M, Sedor G, Lee A, Pasetsky J, Kinslow CJ, Santos GL, Obiri-Yeboah D, Kshettry VR, Helis CA, Chan MD, Beckham TH, McGovern SL, Matsui J, Palmer JD, Bell JB, Mellon EA, Lakomy D, Huang J, Boor I, Rusthoven CG, Sisti MB, Wang TJC
Int J Radiat Oncol Biol Phys
April 11, 2024DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.
Kim JT, Chang SJC, Haghdel A, Ramakrishna RR, Pannullo SC, Schwartz TH, Osborne JR, Magge RS, Fine HA, Cisse B, Stieg P, Lin E, Roytman M, Palmer JD, Karakatsanis NA, Pisapia D, Liechty B, Knisely JPS, Ivanidze J
AJNR Am J Neuroradiol
March 30, 2024[Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response Assessment in Meningiomas.
Ivanidze J, Chang SJ, Haghdel A, Kim JT, RoyChoudhury A, Wu A, Ramakrishna R, Schwartz TH, Cisse B, Stieg P, Muller L, Osborne JR, Magge RS, Karakatsanis NA, Roytman M, Lin E, Pannullo SC, Palmer JD, Knisely JPS
Neuro Oncol
March 22, 2024Long-term radiographic and endocrinological outcomes of stereotactic radiosurgery for recurrent or residual nonfunctioning pituitary adenomas.
Shaaban A, Dumot C, Mantziaris G, Dayawansa S, Peker S, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, Abdel Karim K, El-Shehaby AMN, Emad Eldin RM, Ragab Abdelsalam A, Liscak R, May J, Mashiach E, De Nigris Vasconcellos F, Bernstein K, Kondziolka D, Speckter H, Mota R, Brito A, Bindal SK, Niranjan A, Lunsford LD, Benjamin CG, Almeida T, Mao JZ, Mathieu D, Tourigny JN, Tripathi M, Palmer JD, Matsui J, Crooks J, Wegner RE, Shepard MJ, Sheehan JP
J Neurosurg
March 21, 2024Hypofractionated Stereotactic Radiosurgery in the Management of Brain Metastases.
Lehrer EJ, Breen WG, Singh R, Palmer JD, Brown PD, Trifiletti DM, Sheehan JP
Neurosurgery
March 9, 2024Executive Summary of the American Radium Society Appropriate Use Criteria for Brain Metastases in EGFR-mutated and ALK-fusion Non-Small Cell Lung Cancer.
Nagpal S, Milano MT, Chiang VL, Soltys SG, Brackett A, Halasz LM, Garg AK, Sahgal A, Ahluwalia MS, Tom MC, Palmer JD, Knisley JPS, Chao ST, Gephart MH, Wang TJC, Lo SS, Chang EL
Neuro Oncol
March 4, 2024Novel radiotherapeutic strategies in the management of brain metastases: Challenging the dogma.
Palmer JD, Perlow HK, Lehrer EJ, Wardak Z, Soliman H
Neuro Oncol
March 1, 2024Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity.
Perlow HK, Matsui JK, Ewing A, Cadieux C, Dibs K, Upadhyay R, Blakaj DM, Beyer SJ, Thomas EM, Grecula JC, Raval RR, Palmer JD
Adv Radiat Oncol
February 22, 2024Estimating the risk of brain metastasis for patients newly diagnosed with cancer.
Miccio JA, Tian Z, Mahase SS, Lin C, Choi S, Zacharia BE, Sheehan JP, Brown PD, Trifiletti DM, Palmer JD, Wang M, Zaorsky NG
Commun Med (Lond)
February 6, 2024Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical Experience.
Dibs K, Gogineni E, Jhawar SM, Baliga S, Grecula JC, Mitchell DL, Palmer J, Haglund K, Andraos TY, Zoller W, Ewing A, Bonomi M, Bhateja P, Tinoco G, Liebner D, Rocco JW, Old M, Gamez ME, Chakravarti A, Konieczkowski DJ, Blakaj DM
Cancers (Basel)
February 1, 2024Advancing Beyond the Hippocampus to Preserve Cognition for Patients With Brain Metastases: Dosimetric Results From a Phase 2 Trial of Memory-Avoidance Whole Brain Radiation Therapy.
Perlow HK, Nalin AP, Ritter AR, Addington M, Ward A, Liu M, Nappi C, Blakaj DM, Beyer SJ, Thomas EM, Grecula JC, Raval RR, Kotecha R, Boulter D, Dawson EL, Zoller W, Palmer JD
Adv Radiat Oncol
February 1, 2024Radiation Therapy in the Management of Leptomeningeal Disease From Solid Tumors.
Barbour AB, Kotecha R, Lazarev S, Palmer JD, Robinson T, Yerramilli D, Yang JT
Adv Radiat Oncol
January 17, 2024Emerging insights on management of high-grade glioma.
Shi W, Palmer JD, Alnahhas I
Chin Clin Oncol
January 16, 2024Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer.
Gogineni E, Schaefer D, Ewing A, Andraos T, DiCostanzo D, Weldon M, Christ D, Baliga S, Jhawar S, Mitchell D, Grecula J, Konieczkowski DJ, Palmer J, Jahraus T, Dibs K, Chakravarti A, Martin D, Gamez ME, Blakaj D
Pract Radiat Oncol
January 12, 2024Clinical outcomes following stereotactic body radiation therapy (SBRT) for Non-Spinal Bone Metastases: A Systematic Review and Meta-Analysis.
Singh R, Valluri A, Lehrer EJ, Cao Y, Upadhyay R, Trifiletti DM, Lo SS, Redmond KJ, Sahgal A, Nguyen QN, Palmer JD
Int J Radiat Oncol Biol Phys
January 11, 2024Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease.
Granberg HA, Martins Coelho VP, Palmer JD, Chakravarthy VB
J Neurooncol
January 4, 2024Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases: A Nonrandomized Phase 2 Trial.
Yang Z, Meng J, Mei X, Mo M, Xiao Q, Han X, Zhang L, Shi W, Chen X, Ma J, Palmer J, Shao Z, Zhang Z, Yu X, Guo X
JAMA Oncol
December 27, 2023Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
Upadhyay R, Klamer BG, Perlow HK, White JR, Bazan JG, Jhawar SR, Blakaj DM, Grecula JC, Arnett A, Mestres-Villanueva MA, Healy EH, Thomas EM, Chakravarti A, Raval RR, Lustberg M, Williams NO, Palmer JD, Beyer SJ
Cancers (Basel)
December 22, 2023Effect of cerebral arteriovenous malformation location on outcomes of repeat, single-fraction stereotactic radiosurgery: a matched-cohort analysis.
Mantziaris G, Pikis S, Dumot C, Dayawansa S, Liscak R, May J, Lee CC, Yang HC, Martínez Moreno N, Martinez Álvarez R, Lunsford LD, Niranjan A, Wei Z, Srinivasan P, Tang LW, Nabeel AM, Reda WA, Tawadros SR, Abdel Karim K, El-Shehaby AMN, Emad Eldin RM, Elazzazi AH, Peker S, Samanci Y, Padmanaban V, Jareczek FJ, McInerney J, Cockroft KM, Mathieu D, Aldakhil S, Alzate JD, Kondziolka D, Tripathi M, Palmer JD, Upadhyay R, Lin M, Zada G, Yu C, Cifarelli CP, Cifarelli DT, Shaaban A, Xu Z, Sheehan JP
J Neurosurg
December 14, 2023Stereotactic radiosurgery for non-functioning pituitary tumor: a multicenter study of new pituitary hormone deficiency.
Dumot C, Mantziaris G, Dayawansa S, Peker S, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, AbdelKarim K, El-Shehaby AMN, Emad RM, Abdelsalam AR, Liscak R, May J, Mashiach E, De Nigris Vasconcellos F, Bernstein K, Kondziolka D, Speckter H, Mota R, Brito A, Bindal SK, Niranjan A, Lunsford LD, Benjamin CG, Abrantes de Lacerda Almeida T, Mao J, Mathieu D, Tourigny JN, Tripathi M, Palmer JD, Matsui J, Crooks J, Wegner RE, Shepard MJ, Vance ML, Sheehan JP
Neuro Oncol
December 5, 2023Impact of Multiple Sclerosis Subtypes on Pain Management in Patients With Trigeminal Neuralgia After Stereotactic Radiosurgery: An International Multicenter Analysis.
De Nigris Vasconcellos F, Mashiach E, Alzate JD, Bernstein K, Rotman L, Levy S, Qu T, Wegner RE, Shepard MJ, Patel S, Warnick RE, Moreno NM, Martínez Álvarez R, Picozzi P, Franzini A, Peker S, Samanci Y, Elguindy AN, Palmer JD, Lunsford LD, Jose SG, Wei Z, Niranjan A, Blagui S, Iorio-Morin C, Mathieu D, Briggs RG, Yu C, Zada G, Dayawansa S, Sheehan J, Schulder M, Goenka A, Begley S, Khilji H, Urgošík D, Lišcák R, Kondziolka D
Neurosurgery
November 9, 2023Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci A, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR
Nat Med
October 30, 2023Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: The Role of Vertebral Endplate Disruption.
Dibs K, Facer B, Mageswaran P, Raval R, Thomas E, Gogineni E, Beyer S, Pan J, Klamer B, Ayan A, Bourekas E, Boulter D, Fetko N, Cochran E, Zoller I, Chakravarthy V, Tili E, Elder JB, Lonser R, Elguindy A, Soghrati S, Marras W, Grecula J, Chakravarti A, Palmer J, Blakaj DM
Neurosurgery
October 27, 2023Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
Lehrer EJ, Khosla AA, Ozair A, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, Wei Z, Lunsford LD, Mathieu D, Trudel C, Deibert CP, Malouff TD, Ruiz-Garcia H, Peterson JL, Patel S, Bonney P, Hwang L, Yu C, Zada G, Picozzi P, Franzini A, Attuati L, Prasad RN, Raval RR, Palmer JD, Lee CC, Yang HC, Fakhoury KR, Rusthoven CG, Dickstein DR, Sheehan JP, Trifiletti DM, Ahluwalia MS
J Neurooncol
October 1, 2023Brachial Plexus Tolerance to Standard Fractionation Re-Irradiation: The Ohio State University Experience.
Dibs K, Palmer JD, Konieczkowski DJ, Gogineni E, Mitchell DL, Raval R, Baliga S, Barve R, Elguindy AN, Jhawar SR, Gamez ME, Blakaj DM
Int J Radiat Oncol Biol Phys
October 1, 2023Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: A Toxicity Analysis.
Perlow HK, Matsui JK, Ewing A, Cadieux C, Blakaj DM, Beyer S, Thomas EM, Grecula JC, Raval R, Palmer JD
Int J Radiat Oncol Biol Phys
October 1, 2023Upfront Osimertinib Alone vs. Osimertinib and Radiotherapy for the Treatment of EGFR-Positive NSCLC Brain Metastases: A Multi-Institutional Series.
Dohm AE, Upadhyay R, Tang JD, Oliver DE, Perez BA, Rosenberg SA, Yu HHM, Palmer JD, Beyer S, Owen D, Ahmed KA
Int J Radiat Oncol Biol Phys
October 1, 2023Immune Checkpoint Inhibition and Single Fraction Stereotactic Radiosurgery in Non-Small Cell Lung Cancer Brain Metastases: An International Multicenter Study of 395 Patients.
Lehrer EJ, Gurewitz J, Kondziolka D, Niranjan A, Lunsford LD, Mathieu D, Deibert C, Ruiz-Garcia H, Patel SI, Bonney P, Hwang L, Zada G, Picozzi P, Prasad RN, Palmer JD, Lee CC, Rusthoven CG, Sheehan JP, Trifiletti DM, Ahluwalia M
Int J Radiat Oncol Biol Phys
October 1, 2023WBRT is Associated with Higher Rates of Hematologic Toxicity than Stereotactic Radiosurgery in Brain Metastasis Patients.
McCalla A, Upadhyay R, Perlow HK, Raval R, Beyer S, Blakaj DM, Grecula JC, Palmer JD, Thomas EM
Int J Radiat Oncol Biol Phys
October 1, 2023Advancing beyond the Hippocampus to Preserve Cognition for Patients with Brain Metastases: Dosimetric Results from a Phase 2 Trial of Memory-Avoidance Whole Brain Radiotherapy.
Perlow HK, Nalin A, Ritter A, Addington M, Ward A, Liu M, Nappi C, Blakaj DM, Beyer S, Thomas EM, Grecula JC, Raval R, Kotecha R, Boulter D, Dawson E, Zoller W, Palmer JD
Int J Radiat Oncol Biol Phys
October 1, 2023Patient-Reported Cognitive Outcomes and Survival after Stereotactic Radiosurgery for 15 or More Brain Metastases.
Upadhyay R, Palmer JD, Perlow HK, Schoenhals J, Ghose J, Rajappa P, Blakaj DM, Beyer S, Grecula JC, Sim AJ, Hardesty D, Elder JB, Chakravarti A, Thomas EM, Raval R
Int J Radiat Oncol Biol Phys
October 1, 2023Prognostic Factors for Pediatric, Adolescent, and Young Adult Patients with Non-DIPG Grade 4 Gliomas: A Contemporary Pooled Institutional Experience.
Matsui JK, Allen PK, Perlow HK, Johnson JM, Paulino AC, McAleer MF, Fouladi M, Grosshans DR, Ghia AJ, Li J, Zaky W, Chintagumpala M, Palmer JD, McGovern SL
Int J Radiat Oncol Biol Phys
September 19, 2023Prediction of Rapid Early Progression and Survival Risk with Pre-Radiation MRI in WHO Grade 4 Glioma Patients.
Farzana W, Basree MM, Diawara N, Shboul ZA, Dubey S, Lockhart MM, Hamza M, Palmer JD, Iftekharuddin KM
Cancers (Basel)
September 15, 2023Single Fraction vs. Fractionated Preoperative Radiosurgery for Resected Brain Metastases: a PROPS-BM International Multicenter Cohort Study.
Prabhu RS, Akinyelu T, Vaslow ZK, Matsui JK, Haghighi N, Dan T, Mishra MV, Murphy ES, Boyles S, Perlow HK, Palmer JD, Udovicich C, Patel TR, Wardak Z, Woodworth GF, Ksendzovsky A, Yang K, Chao ST, Asher AL, Burri SH
Int J Radiat Oncol Biol Phys
July 29, 2023The incorporation of cognitive-sparing techniques into prophylactic cranial irradiation in the management of small cell lung cancer.
Bloom JR, Hotca A, Cherry DR, Dickstein DR, Runnels J, Samstein RM, Veluswamy RR, Rosenzweig KE, Brown PD, Trifiletti DM, Palmer JD, Singh R, Breen WG, Lehrer EJ
Chin Clin Oncol
July 26, 2023Concurrent lapatinib with brain radiotherapy in HER2+ breast cancer patients with brain metastases - NRG ONCOLOGY-KROG/ RTOG 1119 phase II randomized trial.
Kim IA, Winter KA, Sperduto PW, Santos JFL, Peereboom DM, Ogunleye T, Boulter D, Fritz JM, Cho KH, Shin KH, Zoberi I, Choi S, Palmer JD, Liem B, Kim YB, Anderson BM, Thakrar AW, Muanza TM, Kim MM, Choi DH, Mehta MP, White JR
Int J Radiat Oncol Biol Phys
July 1, 2023Advances in Radiotherapy for Brain Metastases.
Matsui JK, Perlow HK, Upadhyay R, McCalla A, Raval RR, Thomas EM, Blakaj DM, Beyer SJ, Palmer JD
Surg Oncol Clin N Am
January 1, 2023The Pediatric Proton and Photon Therapy Comparison Cohort: Study Design for a Multicenter Retrospective Cohort to Investigate Subsequent Cancers After Pediatric Radiation Therapy.
Berrington de González A, Gibson TM, Lee C, Albert PS, Griffin KT, Kitahara CM, Liu D, Mille MM, Shin J, Bajaj BVM, Flood TE, Gallotto SL, Paganetti H, Ahmed SK, Eaton BR, Indelicato DJ, Milgrom SA, Palmer JD, Baliga S, Poppe MM, Tsang DS, Wong K, Yock TI
Adv Radiat Oncol
Consulting and Related Relationships
More info forAt The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Palmer has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.
- Servier Pharmaceuticals
- ICOTEC